Author

Arnon Philip Kater

Amsterdam UMCORCID 0000-0003-3190-1891Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

Eric ElderingiD· 3 shared Jamie Lee RoosiD· 2 shared Marco Vincent HaselageriD· 2 shared Aldo JongejaniD· 1 shared Anita E. GrootemaatiD· 1 shared Bauke V. SchomakersiD· 1 shared Caitrin CruddeniD· 1 shared Chaja Feige JacobsiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Eric ElderingORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 3, 2026

Single-cell characterization of 3D CLL spheroid model that recapitulates lymph node microenvironment-driven phenotypes and in vivo drug responses to ibrutinib

Marco V Haselager, Danial Lashgari, Aldo Jongejan…·Eric Eldering

The paper uses a 3D CLL spheroid model to study how lymph node microenvironmental signals influence CLL cell phenotypes and drug responses to ibrutinib.

DOI 10.64898/2026.10.31.763314

humanscRNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintJun 10, 2026

Glutamine-driven mTORC1 activity enforces glycolytic bias, hyperactivation and aberrant proliferation in T cells in chronic B-cell leukemia

Nienke B. Goedhart, Elena Camerini, Gaspard Cretenet…·Helga Simon‐Molas

DOI 10.64898/2026.06.09.731122

humanbulk RNA-seq

𝕏 PostBluesky

BiochemistryProceedings of the National Academy of SciencesPeer-reviewedJun 11, 2025

Disruption of basal CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms

Simon Mobach, Nick D. Bergkamp, Ziliang Ma…·Raimond Heukers

This study shows that disrupting CXCR4 oligomers in lymphoid cancers reduces migration, survival signaling, and tumor growth, while sensitizing cells to venetoclax.

6 citations

humanproteomics

𝕏 PostBluesky